Results from the EMPRISE study presented at ADA 2023 showed empagliflozin was associated with a 23% reduction in the risk of diabetic retinopathy progression in adults with T2D.
Teff Prices Skyrocket, Farmers Blame Authorities, Hoarding Intensifies | The Reporter thereporterethiopia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thereporterethiopia.com Daily Mail and Mail on Sunday newspapers.